ADE000968
1H-pyrrolo[3,2-b]pyridine
AldrichCPR
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
Empirische Formel (Hill-System):
C7H6N2
CAS-Nummer:
Molekulargewicht:
118.14
MDL-Nummer:
UNSPSC-Code:
12352200
PubChem Substanz-ID:
Empfohlene Produkte
![1H-pyrrolo[3,2-c]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/291/250/879d6f32-75bf-4a4a-a366-18cbd62dcc37/640/879d6f32-75bf-4a4a-a366-18cbd62dcc37.png)
![1H-Pyrrolo[2,3-c]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/332/393/b23058ac-c477-42b5-9890-dc5c2af5cec7/640/b23058ac-c477-42b5-9890-dc5c2af5cec7.png)
![4-Iodo-1H-pyrrolo[2,3-b]pyridine AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/296/181/125fbe1d-3d80-4d64-b93a-f92f6ce766ba/640/125fbe1d-3d80-4d64-b93a-f92f6ce766ba.png)
![1H-Pyrrolo[2,3-b]pyridine-2-carboxylic acid AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/238/208/7cc66a5b-8290-425e-8cbf-2364ca9114e9/640/7cc66a5b-8290-425e-8cbf-2364ca9114e9.png)
![1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile AldrichCPR](/deepweb/assets/sigmaaldrich/product/structures/505/605/6b5b15eb-77f0-40a2-bd37-fff8f3526e8e/640/6b5b15eb-77f0-40a2-bd37-fff8f3526e8e.png)
Form
solid
SMILES String
c1cnc2cc[nH]c2c1
InChI
1S/C7H6N2/c1-2-6-7(8-4-1)3-5-9-6/h1-5,9H
InChIKey
XWIYUCRMWCHYJR-UHFFFAOYSA-N
Verwandte Kategorien
Sonstige Hinweise
Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.
NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
Rechtliche Hinweise
Product of Adesis
Signalwort
Danger
H-Sätze
P-Sätze
Gefahreneinstufungen
Acute Tox. 4 Oral - Eye Dam. 1
Lagerklassenschlüssel
11 - Combustible Solids
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Taleen S Der-Ghazarian et al.
ACS chemical neuroscience, 10(7), 3271-3283 (2019-05-03)
5-HT1B receptors (5-HT1BRs) modulate psychostimulant reward and incentive motivation in rodents. Here we investigated the effects of the 5-HT1BR agonist CP94253 (10 mg/kg, IP) on the acquisition and expression of methamphetamine (Meth) conditioned place preference (CPP) in C57BL/6 male mice.
Jessica Karlsson et al.
PloS one, 10(11), e0142711-e0142711 (2015-11-14)
Combined fatty acid amide hydrolase (FAAH) and cyclooxygenase (COX) inhibition is a promising approach for pain-relief. The Flu-AM1 and Ibu-AM5 derivatives of flurbiprofen and ibuprofen retain similar COX-inhibitory properties and are more potent inhibitors of FAAH than the parent compounds.
Bruno Aleksander Martek et al.
Drug testing and analysis, 11(4), 617-625 (2019-02-08)
The high frequency of the synthetic cannabinoid receptor agonists (SCRAs) emergence renders this group of new psychoactive compounds particularly demanding in terms of detection, identification, and responding. Without the available reference material, one of the specific problems is differentiation and
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.